Safiglipron
A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects
Shandong Suncadia Medicine Co · Phase 1/2 · Completed · Enrollment 74
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Treatment group A | n/r | n/r | n/r | n/r | n/r |
| Treatment group B | n/r | n/r | n/r | n/r | n/r |
| Treatment group C | n/r | n/r | n/r | n/r | n/r |
| Treatment group D | n/r | n/r | n/r | n/r | n/r |
| Treatment group E | n/r | n/r | n/r | n/r | n/r |
| Treatment group F | n/r | n/r | n/r | n/r | n/r |
| Treatment group G | n/r | n/r | n/r | n/r | n/r |
| Treatment group H | n/r | n/r | n/r | n/r | n/r |
| Treatment group I | n/r | n/r | n/r | n/r | n/r |
| Treatment group J | n/r | n/r | n/r | n/r | n/r |
| Treatment group K | n/r | n/r | n/r | n/r | n/r |
| Treatment group L | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.